These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 32303386)
1. Reply to Roderick C.N. van den Bergh, Massimo Valerio, Derya Tilki, and Giorgio Gandaglia's Letter to the Editor re: Timothy J. Wilt, Tien N. Vo, Lisa Langsetmo, et al. Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT). Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2020.02.009. Wilt TJ; Dahm P; Brawer MK Eur Urol; 2020 Aug; 78(2):e69-e70. PubMed ID: 32303386 [No Abstract] [Full Text] [Related]
2. Re: Timothy J. Wilt, Tien N. Vo, Lisa Langsetmo, et al. Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT). Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.02.009. van den Bergh RCN; Valerio M; Tilki D; Gandaglia G; Eur Urol; 2020 Aug; 78(2):e67-e68. PubMed ID: 32303383 [No Abstract] [Full Text] [Related]
3. Re: Timothy J. Wilt, Tien N. Vo, Lisa Langsetmo, et al. Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT). Eur Urol 2020;77:713-724: External Validity of the Updated Prostate Cancer Intervention Versus Observation Trial (PIVOT). Rakic N; Keeley J; Abdollah F Eur Urol Oncol; 2020 Aug; 3(4):557-558. PubMed ID: 32546347 [No Abstract] [Full Text] [Related]
4. Reply to E. David Crawford and Bo-Eric Persson's letter to the editor re: Giorgio Gandaglia, Maxine Sun, Jim C. Hu, et al. Gonadotropin-releasing hormone agonists and acute kidney injury in patients with prostate cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.01.026. Gandaglia G; Sun M; Briganti A; Karakiewicz PI Eur Urol; 2014 Aug; 66(2):e36-7. PubMed ID: 24746970 [No Abstract] [Full Text] [Related]
5. Re: Giorgio Gandaglia, Alberto Briganti, Noel Clarke, et al. Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2017.01.039. Alongi F; Aiello D; Mazzola R; Cavalleri S Eur Urol; 2017 Aug; 72(2):e39-e40. PubMed ID: 28318727 [No Abstract] [Full Text] [Related]
6. Reply to Giancarlo Marra, Armando Stabile, Paolo Gontero, Francesco Montorsi, Alberto Briganti, and Giorgio Gandaglia's Letter to the Editor re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019: A Storm in a Teacup. Meissner VH; Gschwend JE; Heck MM Eur Urol; 2022 May; 81(5):e117. PubMed ID: 35131117 [No Abstract] [Full Text] [Related]
7. Reply to Francesco Montorsi and Giorgio Gandaglia's letter to the editor re: Georgios Gakis, Stephen A. Boorjian, Alberto Briganti, et al. The role of radical prostatectomy and lymph node dissection in lymph node-positive prostate cancer: a systematic review of the literature. Eur urol 2014;66:191-9. Gakis G; Stief CG Eur Urol; 2014 Dec; 66(6):e109-10. PubMed ID: 25204223 [No Abstract] [Full Text] [Related]
8. Reply to Massimo Valerio, Mark Emberton, and Hashim U. Ahmed's Letter to the Editor re: Henk G. van der Poel, Roderick C.N. van den Bergh, Erik Briers, et al. Focal Therapy in Primary Localised Prostate Cancer: The European Association of Urology Position in 2018. Eur Urol 2018;74:84-91. van der Poel HG; van den Bergh RCN; Briers E; Cornford P; Govorov A; Henry AM; Lam TB; Mason MD; Rouvière O; De Santis M; Wiegel T; Willemse PM; van Poppel H; Mottet N Eur Urol; 2019 Feb; 75(2):e23-e24. PubMed ID: 30237024 [No Abstract] [Full Text] [Related]
9. Reply to Henk G. van der Poel, Tessa Buckle and Renato Valdes Olmos' letter to the editor re: Steven Joniau, Laura Van den Bergh, Evelyne Lerut, et al. Mapping of pelvic lymph node metastases in prostate cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.06.057. Joniau S; Van den Bergh L Eur Urol; 2013 Feb; 63(2):e21-2. PubMed ID: 23149147 [No Abstract] [Full Text] [Related]
10. Reply to Michael Froehner, Rainer Koch, Manfred P. Wirth's Letter to the Editor re: Malte Rieken, Shahrokh F. Shariat, Luis A. Kluth, et al. Association of Cigarette Smoking and Smoking Cessation with Biochemical Recurrence of Prostate Cancer in Patients Treated with Radical Prostatectomy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.05.038. Rieken M; Shariat SF Eur Urol; 2015 Nov; 68(5):e104-5. PubMed ID: 26314617 [No Abstract] [Full Text] [Related]
11. Reply to Francesco Montorsi and Giorgio Gandaglia's Letter to the Editor re: Riccardo Autorino, Homayoun Zagar, Mirandolino B. Mariano, et al. Perioperative Outcomes of Robotic and Laparoscopic Simple Prostatectomy: A European-American Multi-institutional Analysis. Eur Urol 2015;68:86-94; Re: Matthew Bultitude, Ben Challacombe. Simple Prostatectomy: A Step Too Far for Laparoscopy? Eur Urol 2015;68:95-6. Eur Urol 2015;68:e7-8. Autorino R; Zargar H; Porpiglia F Eur Urol; 2015 Jul; 68(1):e9-10. PubMed ID: 25666848 [No Abstract] [Full Text] [Related]
12. Re: Christian Bolenz, Stephen J. Freedland, Brent K. Hollenbeck, et al. costs of radical prostatectomy for prostate cancer: a systematic review. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.08.059. Rassweiler J Eur Urol; 2013 Apr; 63(4):e53-6. PubMed ID: 23312570 [No Abstract] [Full Text] [Related]
13. Reply to Stephen B. Williams and John F. Ward's Letter to the Editor re: Jan P. Radtke, Constantin Schwab, Maya B. Wolf, et al. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.12.052. Hadaschik BA; Radtke JP Eur Urol; 2016 Sep; 70(3):e79-80. PubMed ID: 26995329 [No Abstract] [Full Text] [Related]
14. Reply to Francesco Montorsi, Simone Scuderi, Alberto Briganti, and Giorgio Gandaglia's Letter to the Editor re: Melline G.M. Schilham, Mark Rijpkema, Tom Scheenen, et al. How Advanced Imaging Will Guide Therapeutic Strategies for Patients with Newly Diagnosed Prostate Cancer in the Years to Come. Eur Urol 2022;82:578-80. Schilham MGM; Rijpkema M; Scheenen T; Hermsen R; Barentsz JO; Sedelaar JPM; Kusters-Vandevelde H; Kerkmeijer LGW; Somford DM; Gotthardt M Eur Urol; 2023 May; 83(5):e133-e134. PubMed ID: 36781337 [No Abstract] [Full Text] [Related]
15. Re: Meelan Bul, Xiaoye Zhu, Antti Rannikko, et al. Radical prostatectomy for low-risk prostate cancer following initial active surveillance: results from a prospective observational study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.02.002. Ates F; Akyol I; Soydan H Eur Urol; 2012 Jul; 62(1):e9; author reply e10-1. PubMed ID: 22512903 [No Abstract] [Full Text] [Related]
16. Reply to Pascal Mouracade's Letter to the Editor re: Giorgio Gandaglia, Nicola Fossati, Armando Stabile, et al. Radical Prostatectomy in Men with Oligometastatic Prostate Cancer: Results of a Single-institution Series with Long-term Follow-up. Eur Urol 2017;72:289-92. Do the Data Violate Kaplan-Meier Assumptions? Gandaglia G; Fossati N; Montorsi F; Briganti A Eur Urol; 2017 Aug; 72(2):e31. PubMed ID: 28214034 [No Abstract] [Full Text] [Related]
17. Re: Steven Joniau, Laura Van den Bergh, Evelyne Lerut, et al. Mapping of pelvic lymph node metastases in prostate cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.06.057. van der Poel HG; Buckle T; Valdes Olmos R Eur Urol; 2013 Feb; 63(2):e20. PubMed ID: 23153744 [No Abstract] [Full Text] [Related]
18. Re: Jean F.P. Lestingi, Giuliano B. Guglielmetti, Quoc-Dien Trinh, et al. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.11.040: Time for a Change? Clinically Meaningful Reasons Why We Will Continue Performing Extended Pelvic Lymph Node Dissection in Selected Patients with Prostate Cancer. Briganti A; Gandaglia G; Graefen M; Joniau S; Karnes RJ; Montorsi F Eur Urol; 2021 May; 79(5):e154-e156. PubMed ID: 33637367 [No Abstract] [Full Text] [Related]
19. Reply to Jonathan Aning, Paul McCoubrie, and Jon Oxley's Letter to the Editor re: Giorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy. Eur Urol 2020;77:733-41. Gandaglia G; Montorsi F; Briganti A Eur Urol; 2020 Nov; 78(5):e200. PubMed ID: 32800726 [No Abstract] [Full Text] [Related]
20. Reply to Gianluca Giannarini, Nazareno Suardi and Alberto Briganti's letter to the editor re: Prasanna Sooriakumaran, Abhishek Srivastava, Shahrokh F. Shariat, et al. A multinational, multi-institutional study comparing positive surgical margin rates among 22 393 open, laparoscopic, and robot-assisted radical prostatectomy patients. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.11.018. Sooriakumaran P; Wiklund P; Roobol MJ; Steyerberg E; Sanchez-Salas R; Cathelineau X; Tewari AK Eur Urol; 2014 Jun; 65(6):e91-2. PubMed ID: 24447573 [No Abstract] [Full Text] [Related] [Next] [New Search]